NOVISMA Trademark

Trademark Overview

On Monday, November 6, 2017, a trademark application was filed for NOVISMA with the United States Patent and Trademark Office. The USPTO has given the NOVISMA trademark a serial number of 87673643. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 10, 2020. This trademark is owned by AveXis, Inc.. The NOVISMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and gene therapy products in the nature of injectable biologic preparations for genetic, neurological, motor neuron, or neuromuscular diseases, disorders and conditions; pharmaceutical preparations and gene therapy products in the nature of biological preparations containing genetic materials for treating spinal muscular atrophy, loss of motor neurons, muscle degeneration, muscle weakness, and paralysis; gene therapy preparation in the nature of biological preparations containing genetic materials for sustained survival motor neuron protein expression
novisma

General Information

Serial Number87673643
Word MarkNOVISMA
Filing DateMonday, November 6, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 10, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 15, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations and gene therapy products in the nature of injectable biologic preparations for genetic, neurological, motor neuron, or neuromuscular diseases, disorders and conditions; pharmaceutical preparations and gene therapy products in the nature of biological preparations containing genetic materials for treating spinal muscular atrophy, loss of motor neurons, muscle degeneration, muscle weakness, and paralysis; gene therapy preparation in the nature of biological preparations containing genetic materials for sustained survival motor neuron protein expression

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 16, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAveXis, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBASEL 4002
CH
Party NameAveXis, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBannockburn, IL 60015

Trademark Events

Event DateEvent Description
Monday, August 10, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 10, 2020ABANDONMENT - NO USE STATEMENT FILED
Friday, July 3, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, July 3, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 3, 2020TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, July 3, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 3, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, July 3, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, January 8, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 6, 2020EXTENSION 3 GRANTED
Monday, January 6, 2020EXTENSION 3 FILED
Monday, January 6, 2020TEAS EXTENSION RECEIVED
Monday, December 30, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 30, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 11, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 9, 2019EXTENSION 2 GRANTED
Tuesday, July 9, 2019EXTENSION 2 FILED
Tuesday, July 9, 2019TEAS EXTENSION RECEIVED
Saturday, January 12, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 10, 2019EXTENSION 1 GRANTED
Thursday, January 10, 2019EXTENSION 1 FILED
Thursday, January 10, 2019TEAS EXTENSION RECEIVED
Tuesday, July 10, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 15, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 15, 2018PUBLISHED FOR OPPOSITION
Wednesday, April 25, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, April 7, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 30, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 30, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 30, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 23, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 23, 2018NON-FINAL ACTION E-MAILED
Friday, February 23, 2018NON-FINAL ACTION WRITTEN
Friday, February 16, 2018ASSIGNED TO EXAMINER
Thursday, November 16, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, November 9, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

novisma preparations motor genetic nature therapy gene pharmaceutical containing neuron materials